NASDAQ: ELOX
Eloxx Pharmaceuticals Inc Stock Ownership - Who owns Eloxx Pharmaceuticals?

Insider buying vs selling

Have Eloxx Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Sumit AggarwalPresident and CEO2026-02-28260,946$0.15
$39.14kBuy

1 of 1

ELOX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ELOX insiders and whales buy or sell their stock.

ELOX Shareholders

What type of owners hold Eloxx Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Paul Edward Klaver679.79%27,439,581$446.72MInsider
Christopher Forbes316.05%12,757,318$207.69MInsider
Tomer Kariv121.40%4,900,249$79.78MInsider
Pontifax Management III GP 2011 Ltd121.40%4,900,249$79.78MInsider
Ran Nussbaum121.40%4,900,249$79.78MInsider
Rajesh B. Parekh119.59%4,827,129$78.59MInsider
Gilad Shabtai83.04%3,351,770$54.57MInsider
Martijn Kleijwegt73.17%2,953,673$48.09MInsider
Harlan Waksal69.51%2,805,750$45.68MInsider
Vaughn Smider52.47%2,117,940$34.48MInsider

1 of 3

ELOX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ELOX0.00%100.00%Net Buying
BOLD0.07%60.34%Net BuyingNet Buying
GOSS1.04%98.96%
ALGS0.01%99.99%
LONA0.06%99.94%Net Buying

Eloxx Pharmaceuticals Stock Ownership FAQ

Who owns Eloxx Pharmaceuticals?

Eloxx Pharmaceuticals (NASDAQ: ELOX) is owned by 0.06% institutional shareholders, 2,029.64% Eloxx Pharmaceuticals insiders, and 0.00% retail investors. Paul Edward Klaver is the largest individual Eloxx Pharmaceuticals shareholder, owning 27.44M shares representing 679.79% of the company. Paul Edward Klaver's Eloxx Pharmaceuticals shares are currently valued at $432.17M.

If you're new to stock investing, here's how to buy Eloxx Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.